These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 12631072

  • 21. Differential effects of modern immunosuppressive agents on the development of intimal hyperplasia.
    Waller JR, Brook NR, Bicknell GR, Nicholson ML.
    Transpl Int; 2004 Jan; 17(1):9-14. PubMed ID: 14551676
    [Abstract] [Full Text] [Related]

  • 22. Sirolimus for Kaposi's sarcoma in renal-transplant recipients.
    Stallone G, Schena A, Infante B, Di Paolo S, Loverre A, Maggio G, Ranieri E, Gesualdo L, Schena FP, Grandaliano G.
    N Engl J Med; 2005 Mar 31; 352(13):1317-23. PubMed ID: 15800227
    [Abstract] [Full Text] [Related]

  • 23. Sirolimus reduces vasculopathy but exacerbates proteinuria in association with inhibition of VEGF and VEGFR in a rat kidney model of chronic allograft dysfunction.
    Ko HT, Yin JL, Wyburn K, Wu H, Eris JM, Hambly BD, Chadban SJ.
    Nephrol Dial Transplant; 2013 Feb 31; 28(2):327-36. PubMed ID: 23229928
    [Abstract] [Full Text] [Related]

  • 24. The impact of cyclosporine dose reduction with or without the addition of rapamycin on functional, molecular, and histological markers of chronic allograft nephropathy.
    Saunders RN, Bicknell GR, Nicholson ML.
    Transplantation; 2003 Mar 27; 75(6):772-80. PubMed ID: 12660500
    [Abstract] [Full Text] [Related]

  • 25. Rapamycin, unlike cyclosporine A, enhances suppressive functions of in vitro-induced CD4+CD25+ Tregs.
    Bocian K, Borysowski J, Wierzbicki P, Wyzgal J, Klosowska D, Bialoszewska A, Paczek L, Górski A, Korczak-Kowalska G.
    Nephrol Dial Transplant; 2010 Mar 27; 25(3):710-7. PubMed ID: 19903662
    [Abstract] [Full Text] [Related]

  • 26. Transforming growth factor-beta1 and tumor growth factor-beta-inducible gene-H3 in nonrenal transplant cyclosporine nephropathy.
    Langham RG, Egan MK, Dowling JP, Gilbert RE, Thomson NM.
    Transplantation; 2001 Dec 15; 72(11):1826-9. PubMed ID: 11740395
    [Abstract] [Full Text] [Related]

  • 27. IGF-I and IGFBP-3 augment transforming growth factor-beta actions in human renal carcinoma cells.
    Rosendahl AH, Forsberg G.
    Kidney Int; 2006 Nov 15; 70(9):1584-90. PubMed ID: 16969385
    [Abstract] [Full Text] [Related]

  • 28. [Can defective TGF-Beta signaling be an Achilles heel in human cancer?].
    Foster DA, Gadir N.
    Ai Zheng; 2008 Aug 15; 27(8):882-4. PubMed ID: 18710627
    [Abstract] [Full Text] [Related]

  • 29. Preclinical in vivo evaluation of rapamycin in human malignant peripheral nerve sheath explant xenograft.
    Bhola P, Banerjee S, Mukherjee J, Balasubramanium A, Arun V, Karim Z, Burrell K, Croul S, Gutmann DH, Guha A.
    Int J Cancer; 2010 Jan 15; 126(2):563-71. PubMed ID: 19634141
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Inhibition of metastatic renal cell carcinomas expressing somatostatin receptors by a targeted cytotoxic analogue of somatostatin AN-238.
    Plonowski A, Schally AV, Nagy A, Kiaris H, Hebert F, Halmos G.
    Cancer Res; 2000 Jun 01; 60(11):2996-3001. PubMed ID: 10850448
    [Abstract] [Full Text] [Related]

  • 35. Upregulation of transforming growth factor-beta1 and vascular endothelial growth factor in cultured keloid fibroblasts: relevance to angiogenic activity.
    Fujiwara M, Muragaki Y, Ooshima A.
    Arch Dermatol Res; 2005 Oct 01; 297(4):161-9. PubMed ID: 16184401
    [Abstract] [Full Text] [Related]

  • 36. The relationship of transforming growth factor-beta1 gene polymorphism, its plasma level, and gingival overgrowth in renal transplant recipients receiving different immunosuppressive regimens.
    Radwan-Oczko M, Boratyńska M, Zietek M, Zołedziewska M, Jonkisz A.
    J Periodontol; 2006 May 01; 77(5):865-73. PubMed ID: 16671880
    [Abstract] [Full Text] [Related]

  • 37. Pirfenidone inhibits obliterative airway disease in mouse tracheal allografts.
    Zhou H, Latham CW, Zander DS, Margolin SB, Visner GA.
    J Heart Lung Transplant; 2005 Oct 01; 24(10):1577-85. PubMed ID: 16210133
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. A selective small molecule c-MET Inhibitor, PHA665752, cooperates with rapamycin.
    Ma PC, Schaefer E, Christensen JG, Salgia R.
    Clin Cancer Res; 2005 Mar 15; 11(6):2312-9. PubMed ID: 15788682
    [Abstract] [Full Text] [Related]

  • 40. Ubenimex inhibits cell proliferation, migration and invasion in renal cell carcinoma: the effect is autophagy-associated.
    Liu S, Xie F, Wang H, Liu Z, Liu X, Sun L, Niu Z.
    Oncol Rep; 2015 Mar 15; 33(3):1372-80. PubMed ID: 25571917
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.